Clinical Trials Browser

Phase 2/3 × Esophageal Squamous Cell Carcinoma × Neoadjuvant Therapy × Clear all

NCT03623737 2022-06-07

Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC

Phase 2/3 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma